Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on September 26, 2012. The filing announces the consolidated financial results for the first quarter of fiscal year 2013. The report serves to furnish a press release (Exhibit 99.1) containing these results.
Key Financial Metrics
The provided text is a cover document for the 8-K filing and does not contain specific numerical data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the input content.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms that results for the first quarter of fiscal year 2013 were announced.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the report, including the press release, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other filings unless expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (the press release dated September 26, 2012) to obtain actual financial figures for Q1 FY2013.
- Confirm the fiscal year end date for Landec Corporation to accurately compare the "first quarter of fiscal year 2013" with prior periods.
- Note that this specific 8-K document is for informational purposes regarding the release of results and does not itself contain the audited or reviewed financial statements.